<clinical_study>
<study_id>
<org_name>
  Otsuka
</org_name>
<org_full_name>
  Otsuka Pharmaceutical Development &amp; Commercialization, Inc.
</org_full_name>
<org_study_id>
  31-08-256
</org_study_id>
<nct_id>
  NCT01111552
</nct_id>
</study_id>
<is_fda_regulated>
  Yes
</is_fda_regulated>
<is_section_801>
  No
</is_section_801>
<brief_title>
<textblock>
  Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
</textblock>
</brief_title>
<acronym>
  ACES 256
</acronym>
<official_title>
<textblock>
  A Multicenter, Randomized, Double-blind Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder
</textblock>
</official_title>
<study_sponsor>
<lead_sponsor>
<agency>
  Otsuka Pharmaceutical Development &amp; Commercialization, Inc.
</agency>
</lead_sponsor>
<sponsor>
<agency>
  Covance
</agency>
</sponsor>
</study_sponsor>
<resp_party>
<name_title>
  Frances Wulf, Manager, Global Clinical Development
</name_title>
<organization>
  Otsuka Pharmaceutical Development &amp; Commercialization, Inc.
</organization>
</resp_party>
<oversight_info>
<regulatory_authority>
  United States: Food and Drug Administration
</regulatory_authority>
<has_dmc>
  Yes
</has_dmc>
</oversight_info>
<brief_summary>
<textblock>
  This will be a multicenter, randomized, double-blind study designed to assess the efficacy, safety and tolerability of an oral Aripiprazole/Escitalopram combination therapy in subjects with MDD who have demonstrated an incomplete response to a prospective trial of Escitalopram, and report a treatment history for the current MDD episode of an inadequate response to at least one and no more than three adequate trials of an approved antidepressant other than Escitalopram. An inadequate response is defined as less than a 50% reduction in depressive symptom severity as assessed by the subject&apos;s self-report on the Massachusetts General Hospital Antidepressant Treatment Response Questionnaire (ATRQ) and evaluated by the investigator as part of the subject&apos;s medical and psychiatric history. An adequate trial is defined as an antidepressant treatment for at least 6 weeks duration (or at least 3 weeks for combination treatments) at an approved dose as specified in the ATRQ.
</textblock>
</brief_summary>
<detailed_descr>
<textblock>
  The study will be organized as follows:
  &#8226;	Screening Phase 
  &#8226;	Single-blind Prospective Treatment Phase 
  &#8226;	Single-blind Continuation Phase (Responder) or Double-blind Randomization Phase (non-Responder)
  &#8226;	30 day Post Treatment Follow-up 
 
  Assigned Interventions:
  &#8226;	Escitalopram monotherapy 
  &#8226;	Aripiprazole/Escitalopram combination therapy
  &#8226;	Aripiprazole monotherapy
</textblock>
</detailed_descr>
<status_block>
<status>
Terminated 
</status>
<date>
2011-07 
</date>
</status_block>
<start_date>
<date>
  2010-07
</date>
</start_date>
<last_follow_up_date
 type="Anticipated"
>
<date>
  2012-10
</date>
</last_follow_up_date>
<primary_compl_date
 type="Anticipated"
>
<date>
  2012-09
</date>
</primary_compl_date>
<phase_block>
<phase>
  Phase 3
</phase>
</phase_block>
<study_type>
  Interventional
</study_type>
<design>
  Treatment
</design>
<design>
  Randomized
</design>
<design>
  Double Blind (Subject, Investigator)
</design>
<design>
  Single Group Assignment
</design>
<design>
  Safety/Efficacy Study
</design>
<number_of_arms>
  3
</number_of_arms>
<primary_outcome>
<measure>
  Mean change in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score
</measure>
<time_frame>
  from Week 8 to Week 14
</time_frame>
<description>
<textblock>
  The primary efficacy endpoint is the mean change from the end of Week 8 Visit to the end of Week 14 Visit in the Montgomery-Asberg Depression Rating Scale (MADRS) Total Score.
</textblock>
</description>
<safety_issue>
  No
</safety_issue>
</primary_outcome>
<enrollment
 type="Anticipated"
>
  1200
</enrollment>
<condition>
  Major Depressive Disorder (MDD)
</condition>
<arm_group>
<arm_group_label>
  Escitalopram monotherapy
</arm_group_label>
<arm_type>
  Active Comparator
</arm_type>
<description>
<textblock>
</textblock>
</description>
</arm_group>
<arm_group>
<arm_group_label>
  Aripiprazole monotherapy
</arm_group_label>
<arm_type>
  Active Comparator
</arm_type>
<description>
<textblock>
</textblock>
</description>
</arm_group>
<arm_group>
<arm_group_label>
  Aripiprazole/Escitalopram combination therapy
</arm_group_label>
<arm_type>
  Active Comparator
</arm_type>
<description>
<textblock>
</textblock>
</description>
</arm_group>
<intervention>
<intervent_type>
  Drug
</intervent_type>
<primary_name>
  Escitalopram
</primary_name>
<description>
<textblock>
  Escitalopram monotherapy
</textblock>
</description>
<arm_group_label>
  Escitalopram monotherapy
</arm_group_label>
</intervention>
<intervention>
<intervent_type>
  Drug
</intervent_type>
<primary_name>
  Aripiprazole
</primary_name>
<description>
<textblock>
  Aripiprazole monotherapy
</textblock>
</description>
<arm_group_label>
  Aripiprazole monotherapy
</arm_group_label>
</intervention>
<intervention>
<intervent_type>
  Drug
</intervent_type>
<primary_name>
  Aripiprazole/Escitalopram combination
</primary_name>
<description>
<textblock>
  Aripiprazole/Escitalopram combination therapy
</textblock>
</description>
<arm_group_label>
  Aripiprazole/Escitalopram combination therapy
</arm_group_label>
</intervention>
<eligibility>
<criteria>
<textblock>
  Inclusion Criteria:
  &#8226;	Subjects with a current diagnosis of a major depressive episode. The current depressive episode must be &#8805; 8 weeks in duration 
  &#8226;	Subjects willing to discontinue all prohibited psychotropic medication starting from the time of signing the informed consent and during the study period 
  &#8226;	Subjects with a HAM-D17 Total Score &#8805; 18 at the Baseline Visit for the Prospective Treatment Phase 
 
 
 
  Exclusion Criteria:
  &#8226;	Lack of prior treatment with an antidepressant during the current depressive episode
  &#8226;	Subjects who report treatment with adjunctive or monotherapy antipsychotic treatment during the current depressive episode. 
  &#8226;	Subjects experiencing hallucinations, delusions or any psychotic symptomatology in the current depressive episode
  &#8226;	Subjects with epilepsy or significant history of seizure disorders
  &#8226;	Subjects with a clinically significant current diagnosis of borderline, antisocial, paranoid, schizoid, schizotypal or histrionic personality disorder
  &#8226;	Subjects who have received electroconvulsive therapy (ECT) in the last 10 years
</textblock>
</criteria>
<healthy_volunteers>
  No
</healthy_volunteers>
<gender>
  Both
</gender>
<minimum_age>
  18 Years
</minimum_age>
<maximum_age>
  65 Years
</maximum_age>
</eligibility>
<contact>
<name>
  Study Information
</name>
<phone>
</phone>
<phone_ext>
</phone_ext>
<email>
  acesmddstudyinfo@mmgct.com
</email>
</contact>
<location>
<facility>
<name>
</name>
<address>
<city>
  Birmingham
</city>
<state>
  Alabama
</state>
<zip>
  35216
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Little Rock
</city>
<state>
  Arkansas
</state>
<zip>
  72223
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Redlands
</city>
<state>
  California
</state>
<zip>
  92374
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  San Diego
</city>
<state>
  California
</state>
<zip>
  92128
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Mission Viejo
</city>
<state>
  California
</state>
<zip>
  92691
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Garden Grove
</city>
<state>
  California
</state>
<zip>
  95231
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Imperial
</city>
<state>
  California
</state>
<zip>
  92251
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Carson
</city>
<state>
  California
</state>
<zip>
  90746
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Atlanta
</city>
<state>
  Georgia
</state>
<zip>
  30308
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Atlanta
</city>
<state>
  Georgia
</state>
<zip>
  30328
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Hoffman Estates
</city>
<state>
  Illinois
</state>
<zip>
  60169
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Terre Haute
</city>
<state>
  Indiana
</state>
<zip>
  47802
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Prairie Village
</city>
<state>
  Kansas
</state>
<zip>
  66206
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Overland Park
</city>
<state>
  Kansas
</state>
<zip>
  66211
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Wichita
</city>
<state>
  Kansas
</state>
<zip>
  67207
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Baltimore
</city>
<state>
  Maryland
</state>
<zip>
  21204
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  New York
</city>
<state>
  New York
</state>
<zip>
  10021
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Toledo
</city>
<state>
  Ohio
</state>
<zip>
  43623
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
Bartlett 
</city>
<state>
  Tennessee
</state>
<zip>
  38134
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Wichita Falls
</city>
<state>
  Texas
</state>
<zip>
  76309
</zip>
<country>
  United States
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Everton Park
</city>
<state>
  Queensland
</state>
<zip>
  4053
</zip>
<country>
  Australia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Brisbane
</city>
<state>
  Queensland
</state>
<zip>
  4000
</zip>
<country>
  Australia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Malvern
</city>
<state>
  Victoria
</state>
<zip>
  3144
</zip>
<country>
  Australia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Melbourne
</city>
<state>
  Victoria
</state>
<zip>
  3004
</zip>
<country>
  Australia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Fremantle
</city>
<state>
  Western Australia
</state>
<zip>
  6959
</zip>
<country>
  Australia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Tserova Koriya
</city>
<state>
</state>
<zip>
  5047
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Rousse
</city>
<state>
</state>
<zip>
  7003
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Plovdiv
</city>
<state>
</state>
<zip>
  4000
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Sofia
</city>
<state>
</state>
<zip>
  1431
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Bourgas
</city>
<state>
</state>
<zip>
  8000
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Sofia
</city>
<state>
</state>
<zip>
  1113
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Pleven
</city>
<state>
</state>
<zip>
  5800
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Varna
</city>
<state>
</state>
<zip>
  9000
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Novi Iskar
</city>
<state>
</state>
<zip>
  1282
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Sofia
</city>
<state>
</state>
<zip>
  1606
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Lovech
</city>
<state>
</state>
<zip>
  5500
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Tsarev Brod
</city>
<state>
</state>
<zip>
  9747
</zip>
<country>
  Bulgaria
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Tirupati
</city>
<state>
  Andhra Pradesh
</state>
<zip>
  517507
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Vijaywada
</city>
<state>
  Andhra Pradesh
</state>
<zip>
  500072
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Manipal
</city>
<state>
  Karnataka
</state>
<zip>
  576104
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Pune
</city>
<state>
  Maharashtra
</state>
<zip>
  411004
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Ludhiana
</city>
<state>
  Punjab
</state>
<zip>
  141001
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Chennai
</city>
<state>
  Tamil Nadu
</state>
<zip>
  600003
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Kanpur
</city>
<state>
  Uttar Pradesh
</state>
<zip>
  208005
</zip>
<country>
  India
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Quezon City
</city>
<state>
  NCR
</state>
<zip>
  1102
</zip>
<country>
  Philippines
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Quezon City
</city>
<state>
  NCR
</state>
<zip>
  1101
</zip>
<country>
  Philippines
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
  Study Site 1
</name>
<address>
<city>
  Bucuresti
</city>
<state>
</state>
<zip>
  041914
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Bucuresti
</city>
<state>
</state>
<zip>
  010825
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Craiova
</city>
<state>
</state>
<zip>
  200620
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Targu Mures
</city>
<state>
</state>
<zip>
  540139
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Craiova
</city>
<state>
</state>
<zip>
  540139
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Iasi
</city>
<state>
</state>
<zip>
  700282
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Targoviste
</city>
<state>
</state>
<zip>
  130081
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Bucuresti
</city>
<state>
</state>
<zip>
  030455
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
  Study Site 2
</name>
<address>
<city>
  Bucuresti
</city>
<state>
</state>
<zip>
  041914
</zip>
<country>
  Romania
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Svidnik
</city>
<state>
</state>
<zip>
  8901
</zip>
<country>
  Slovakia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Zlate Moravce
</city>
<state>
</state>
<zip>
  95301
</zip>
<country>
  Slovakia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Trencin
</city>
<state>
</state>
<zip>
  91101
</zip>
<country>
  Slovakia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Michalovce
</city>
<state>
</state>
<zip>
  07101
</zip>
<country>
  Slovakia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<location>
<facility>
<name>
</name>
<address>
<city>
  Rimavska Sobota
</city>
<state>
</state>
<zip>
  97901
</zip>
<country>
  Slovakia
</country>
</address>
</facility>
<status>
  Recruiting
</status>
</location>
<keyword>
  Major Depressive Disorder
</keyword>
<keyword>
  MDD
</keyword>
<keyword>
  Depression
</keyword>
<initial_release_date>
  2010-04-22
</initial_release_date>
<last_release_date>
2011-07-15 
</last_release_date>
<init_disposition_release_date>
</init_disposition_release_date>
<init_results_release_date>
</init_results_release_date>
</clinical_study>
